ASCO 50th Annual Meeting
May 30, 2014 ‐ June 02, 2014 in McCormick Place Chicago, Illinois, USA
Cellectis will be present at the ASCO Annual Meeting
André Choulika, PhD, CEO of Cellectis and Mathieu Simon, MD, Executive Vice President will be attending this year's ASCO meeting in Chicago, IL on May the 30th to June 3rd, 2014.
Cellectis is developing innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target liquid and solid tumors. Cellectis’ state-of-the-art genome engineering technologies together with the next generation of msCAR and an allogeneic cGMP manufacturing process for CART products take this new paradigm shift in oncology to the next level of the industry. The Company’s pipeline focuses on leukemia and solid tumors.
ASCO is a professional oncology society committed to conquering cancer through research, education, prevention and delivery of high-quality patient care.